National Bank of Canada’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.5K Hold
513
﹤0.01% 1959
2025
Q4
$52.9K Hold
513
﹤0.01% 1950
2025
Q3
$46.3K Hold
513
﹤0.01% 1958
2025
Q2
$45.1K Hold
513
﹤0.01% 1988
2025
Q1
$46.7K Buy
513
+72
+16% +$6.48K ﹤0.01% 1898
2024
Q4
$38K Sell
441
-13,235
-97% -$1.2M ﹤0.01% 2027
2024
Q3
$1.3M Sell
13,676
-100
-0.7% -$9.5K ﹤0.01% 1066
2024
Q2
$1.26M Sell
13,776
-220
-2% -$19.6K ﹤0.01% 1014
2024
Q1
$1.25M Buy
13,996
+353
+3% +$30.9K ﹤0.01% 1093
2023
Q4
$1.13M Sell
13,643
-1,779
-12% -$139K ﹤0.01% 1115
2023
Q3
$1.21M Sell
15,422
-209
-1% -$16.9K ﹤0.01% 1147
2023
Q2
$1.23M Sell
15,631
-672
-4% -$52.6K ﹤0.01% 1092
2023
Q1
$1.27M Sell
16,303
-1,025
-6% -$79K ﹤0.01% 974
2022
Q4
$1.35M Sell
17,328
-2,533
-13% -$187K ﹤0.01% 989
2022
Q3
$1.33M Sell
19,861
-484
-2% -$35.7K 0.01% 894
2022
Q2
$1.56M Buy
20,345
+16,205
+391% +$1.27M 0.01% 864
2022
Q1
$330K Sell
4,140
-300
-7% -$23K ﹤0.01% 1383
2021
Q4
$342K Buy
+4,440
New +$330K ﹤0.01% 1343

Other funds holding PPH

National Bank of Canada's PPH Position: Q1 2026 in Review

National Bank of Canada held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 513 shares worth $53.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.

National Bank of Canada first reported a position in PPH in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.56M in Q2 2022. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • National Bank of Canada held 513 shares of VanEck Pharmaceutical ETF worth $53.5K as of Q1 2026.
  • National Bank of Canada left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1959 holding.
  • National Bank of Canada first reported a position in VanEck Pharmaceutical ETF in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's VanEck Pharmaceutical ETF position peaked at $1.56M in Q2 2022.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.